Imogen Calderwood
A GERMAN healthcare giant is to produce its entire global aspirin output in Spain, following the government’s reforms to lure foreign investors back to Spain.
Bayer AG has spent €6 million in Asturias in order to get the Langreo plant producing all of its aspirin.
It is good news for Spain which has seen investments in new production sites or the extension of existing ones rise 8.8% from a year ago to 15.8 billion, according to statistics.
“Spain’s qualified and flexible labour force, its competitive production costs and its strategic location make it very attractive,” said Manuel Fernandez Ortega, manager of Bayer’s Langreo plant.
The company employs about 2,160 people in five Spanish facilities.
